Skip to main content
Stoke Therapeutics

Director/Senior Director, National Accounts - East

RemoteUnited States, United Kingdom only
Published
Role
Sales
Experience
Lead
Employment
Full-time
$238k–$268k/yr
Check eligibility

Open to US, GB only. Set where you work from to check your eligibility.

No BS summary

Market access leader for US national payer accounts, with 15+ years in pharma/biotech and 10+ years in payer account management. Must have rare/orphan product coverage experience, pre-launch payer strategy, and hands-on miscellaneous J code experience. Remote/field-based in the US with about 50% travel and proximity to a major US airport preferred.

What you'll do

  • Develop and execute pre-launch and launch-phase access strategies, establishing Stoke’s presence with key accounts.
  • Serve as strategic leader for key accounts in the region
  • Develop account-specific action plans that shorten the timeline from FDA approval to an active, positive coverage determination.
  • Build payer relationships and establish Stoke’s credibility with medical benefit policy decision-makers before NDA submission, ensuring seamless coverage between approval and patient access.
  • Develop multi-year access plans that anticipate commercial cycles and competitive coverage shifts, balancing account-level execution with a national access strategy.
  • Educate payers on clinical evidence, FDA labeling, treatment guidelines, and health-economic data to support coverage decisions and eliminate utilization management barriers (step edits, PA criteria, NDC blocks).
  • Monitor medical policy language at each account and partner with Medical Affairs, HEOR, and Advocacy to respond to and proactively shape policy criteria.
  • Proactively engage payer Medical Directors to obtain informal guidance letters or billing instructions that bridge the gap between launch and permanent J code assignment.
  • Engage and influence policy decision-makers for a medical benefit product to achieve desired coverage policy outcomes.
  • Serve as the company’s subject-matter expert on buy-and-bill reimbursement dynamics for products carrying a miscellaneous J code (J3490/J3590) pending assignment of a permanent, product-specific J code.
  • Educate payer medical policy teams on correct claims submission procedures, billing unit conventions, and NDC-to-J code crosswalk requirements to minimize claim denials during the unclassified code period.
  • Drive alignment across Stoke’s commercial team and field medical team without direct reporting relationships, building internal coalitions across Medical, HEOR, Reimbursement, Government Affairs, Legal, Trade & Distribution, and Patient Services to ensure integrated execution.
  • Ensure effective communication and coordination between the field reimbursement team and patient services to support a high approval success rate and timely patient access.
  • Engage authentically with the Dravet syndrome patient and caregiver community and incorporate community insights into payer engagement in a compelling and compliant manner.
  • Conduct all payer engagements in full compliance with company SOPs, OIG guidelines, PhRMA Code, and applicable federal and state regulations.
  • Navigate the unique complexity of a first-in-class disease-modifying ASO therapy with no established coverage precedent, finding creative and compliant paths to access.

What they require

  • Bachelor’s degree required; advanced degree (MBA, MPH, PharmD) preferred.
  • 15+ years in pharma/biotech; minimum 10 years in payer account management with lead responsibility for one of the three large PBM and National accounts.
  • Proven track record of achieving positive coverage outcomes for orphan designation or rare disease products on the medical benefit.
  • Pre-launch payer strategy experience—not just maintenance of established access.
  • Hands-on experience navigating a miscellaneous J code (J3490/J3590) environment, including transition to a permanent product-specific code.
  • Strong command of managed care economics, formulary management, utilization management, and coverage policy development processes at national payers.
  • Rare pediatric or neurological disease product launch experience; CNS or epilepsy payer experience a significant differentiator.
  • Familiarity with disease-modifying therapy and gene testing reimbursement pathways as established according to payer policy.
  • Experience at a company building its commercial infrastructure for the first time—startup or early commercial-stage biotech.
  • Exceptional ability to influence across functions without direct authority.
  • Passion for patient access and rare-disease impact.
  • This is a remote / field-based position; proximity to a major US airport preferred.
  • Travel: approximately 50%.

Benefits

  • Annual bonus
  • Equity participation
  • Medical insurance
  • Dental insurance
  • Vision insurance
  • Life insurance
  • Long- and short-term disability insurance
  • Paid parental leave
  • 401K plan with company match
  • Unlimited vacation time
  • Tuition assistance
  • Participation in our Employee Stock Purchase Program (ESPP)
  • Flexibility in work arrangements that balance individual’s needs and preferences with the needs of our business

Stoke Therapeutics is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO approach, Stoke is developing antisense oligonucleotides to selectively restore naturally-occurring protein levels.

🇺🇸 United StatesBiotechMid-sizestoketherapeutics.com

Details

EngagementW-2 only
Apply routeGreenhouse
$238k–$268k/yr